UroGen Pharma CMO Mark Schoenberg sells 60,677 common shares for $2.86 million
URGN•Chief medical officer sells shares
- UroGen Pharma Chief Medical Officer Mark Schoenberg sold 60,677 ordinary shares on Aug. 20, 2026.
- Sale priced at USD 47.05 per share on a weighted-average basis.
- Post-transaction holding totaled 59,086 ordinary shares.
